(Q40560343)

21 September 2017

Bioluminescent imaging of Cdk2 inhibition in vivo (English)

1 reference

21 September 2017

0 references

9

William G Kaelin

1 reference

21 September 2017

Guo-Jun Zhang

1

1 reference

21 September 2017

Michal Safran

2

1 reference

21 September 2017

Wenyi Wei

3

1 reference

21 September 2017

Erik Sorensen

4

1 reference

21 September 2017

Peter Lassota

5

1 reference

21 September 2017

Nikolai Zhelev

6

1 reference

21 September 2017

Donna S Neuberg

7

1 reference

21 September 2017

Geoffrey Shapiro

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

2 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

10

1 reference

21 September 2017

643-648

1 reference

21 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1047

21 September 2017

0 references

cites work

Shedding light onto live molecular targets

1 reference

Noninvasive real-time imaging of apoptosis

21 January 2018

1 reference

A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C

21 January 2018

1 reference

Engineering a bioluminescent indicator for cyclic AMP-dependent protein kinase

21 January 2018

1 reference

Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells

21 January 2018

1 reference

Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering

21 January 2018

1 reference

Measurement of protein phosphorylation by covalent modification of firefly luciferase.

21 January 2018

1 reference

SCF and Cullin/Ring H2-based ubiquitin ligases

21 January 2018

1 reference

The anaphase-promoting complex: it's not just for mitosis any more.

21 January 2018

1 reference

Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex

21 January 2018

1 reference

Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

21 January 2018

1 reference

Cyclin-dependent kinase inhibitors for treating cancer

21 January 2018

1 reference

Cyclin-dependent kinases as new targets for the prevention and treatment of cancer

21 January 2018

1 reference

Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors

21 January 2018

1 reference

Distinct roles for cyclin-dependent kinases in cell cycle control

21 January 2018

1 reference

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

21 January 2018

1 reference

Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunit

21 January 2018

1 reference

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

21 January 2018

1 reference

Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

21 January 2018

1 reference

A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase

21 January 2018

1 reference

Proliferation of cancer cells despite CDK2 inhibition.

21 January 2018

1 reference

21 January 2018

1 reference

In vivo cultivation of tumor cells in hollow fibers

21 January 2018

1 reference

Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model

21 January 2018

1 reference

7 January 2021

Tumor induction of VEGF promoter activity in stromal cells

1 reference

7 January 2021

Engineering aequorin to measure Ca2+ in defined compartments of living cells

1 reference

7 January 2021

In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)

1 reference

7 January 2021

Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A

1 reference

7 January 2021

Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1047

1 reference

21 September 2017

1 reference